Arrr! The Dreaded Relapsed DLBCL be no match for the Complete Interim Response, for SCT be superior to CAR T!
2023-12-12
Arrr! Fer patients sufferin' from a relapsed DLBCL in a complete remission, usin' auto-HCT be bringin' ye a lower rate o' relapse/progression, and a lengthier progression-free survival than that fancy CAR T therapy. Avast! <i>MDedge News</i>
Arrr, me hearties! Listen up, ye scurvy dogs, for I bring ye news from the land of medicine. 'Tis a tale about relapsed DLBCL, a disease that be plaguing many a soul. Now, it seems that there be two ways to treat this foul beast - auto-HCT and CAR T therapy. But beware, for the two be quite different!According to the wise men of MDedge News, in patients who be relapsed yet in complete remission, auto-HCT be the better choice. Why, ye ask? Well, it be all about the rate of relapse/progression, ye see. Auto-HCT be havin' a lower rate, which be good news for those wantin' to keep the beast at bay.
But that ain't all, me mateys! Auto-HCT also be offerin' a longer progression-free survival. Now, what be this, ye ask? Well, it means that ye be havin' more time before the beast be comin' back to haunt ye. And who wouldn't want that?
But hold yer horses, lads and lasses! Let's not be forgettin' about CAR T therapy. 'Tis a mighty fine treatment as well, but when compared to auto-HCT in this tale, it be fallin' short. So if ye be findin' yerself in the clutches of relapsed DLBCL in a complete remission, ye might want to set sail with auto-HCT.
Now, I be no doctor meself, but these be the words of the wise MDedge News. So take heed, me hearties, and choose yer treatment wisely. And remember, a sense of humor be as important as a good crew when battlin' the beasts of the medical world. Arrr!